References
[1] Muncan B. Cardiovascular disease in racial/ethnic minority
populations: illness burden and overview of community-based
interventions. Public Health Rev [Internet]. 2018;39(1). Available
from: http://dx.doi.org/10.1186/s40985-018-0109-4
[2] Cardiovascular disease [Internet]. Nhs.uk. Available from:
https://www.nhs.uk/conditions/cardiovascular-disease/. Accessed
August 23, 2020.
[3] Cardiovascular diseases (CVDs) [Internet]. Who.int.
Available from:
https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
Accessed August 23, 2020.
[4] Francis DK, On behalf of the U.S. Caribbean Alliance for Health
Disparities Research Group (USCAHDR), Bennett NR, Ferguson TS, Hennis
AJM, Wilks RJ, et al. Disparities in cardiovascular disease among
Caribbean populations: a systematic literature review. BMC Public Health
[Internet]. 2015;15(1). Available from:
http://dx.doi.org/10.1186/s12889-015-2166-7
[5] Cooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L,
Havlik R, et al. Trends and disparities in coronary heart disease,
stroke, and other cardiovascular diseases in the United States: Findings
of the national conference on cardiovascular disease prevention.
Circulation. 2000;102(25):3137–47.
[6] McGuire TG, Alegria M, Cook BL, Wells KB, Zaslavsky AM.
Implementing the Institute of Medicine definition of disparities: an
application to mental health care. Health Serv Res.
2006;41(5):1979–2005.
[7] Hackler E III, Lew J, Gore MO, Ayers CR, Atzler D, Khera A, et
al. Racial differences in cardiovascular biomarkers in the general
population. J Am Heart Assoc [Internet]. 2019;8(18). Available from:
http://dx.doi.org/10.1161/jaha.119.012729
[8] Youmans QR, Hastings-Spaine L, Princewill O, Shobayo T, Okwuosa
IS. Disparities in cardiovascular care: Past, present, and solutions.
Cleve Clin J Med. 2019;86(9):621–32.
[9] Meadows TA, Bhatt DL, Cannon CP, Gersh BJ, Röther J, Goto S, et
al. Ethnic differences in cardiovascular risks and mortality in
atherothrombotic disease: insights from the Reduction of
Atherothrombosis for Continued Health (REACH) registry. Mayo Clin Proc.
2011;86(10):960–7.
[10] Davis AM, Vinci LM, Okwuosa TM, Chase AR, Huang ES.
Cardiovascular health disparities. Med Care Res Rev.
2007a;64(5_suppl):29S-100S.
[11] 2018 Practice Guidelines for the management of arterial
hypertension of the European Society of Hypertension and the European
Society of Cardiology. Journal of Hypertension. 2019;37(2):456.
[12] Joint British Societies’ consensus recommendations for the
prevention of cardiovascular disease (JBS3). Heart. 2014;100(Suppl
2):ii1-ii67.
[13] Cappuccio F, Cook D, Atkinson R, Strazzullo P. Prevalence,
detection, and management of cardiovascular risk factors in different
ethnic groups in south London. Heart. 1997;78(6):555-563.
[14] Dorans K, Mills K, Liu Y, He J. Trends in Prevalence and
Control of Hypertension According to the 2017 American College of
Cardiology/American Heart Association (ACC/AHA) Guideline. Journal of
the American Heart Association. 2018;7(11).
[15] George, MG, Schieb, LJ, Ayala, C Pulmonary hypertension
surveillance: United States, 2001 to 2010. Chest 2014; 146(2): 476–495.
[16] Kishi, S, Reis, JP, Venkatesh, BA Race-ethnic and sex
differences in left ventricular structure and function: the Coronary
Artery Risk Development in Young Adults (CARDIA) Study. J Am Heart Assoc
2015; 4(3): e001264[17] Yang BQ, Assad TR, O’Leary JM, Xu M,
Halliday SJ, D’Amico RW, et al. Racial differences in patients referred
for right heart catheterization and risk of pulmonary hypertension. Pulm
Circ. 2018;8(2):2045894018764273.
[18] Elliott W. NICE clinical guideline 127: Hypertension: Clinical
management of primary hypertension in adults. Yearbook of Cardiology.
2012;2012:1-3.
[19] Campia U, Choucair W, Bryant M, Waclawiw M, Cardillo C, Panza
J. Reduced endothelium-dependent and -independent dilation of
conductance arteries in African Americans. Journal of the American
College of Cardiology. 2002;40(4):754-760.
[20] Gabler N, French B, Strom B, Liu Z, Palevsky H, Taichman D et
al. Race and Sex Differences in Response to Endothelin Receptor
Antagonists for Pulmonary Arterial Hypertension. Chest.
2012;141(1):20-26.
[21] Myrand S, Sekiguchi K, Man M, Lin X, Tzeng R, Teng C et al.
Pharmacokinetics/Genotype Associations for Major Cytochrome P450 Enzymes
in Native and First- and Third-generation Japanese Populations:
Comparison With Korean, Chinese, and Caucasian Populations. Clinical
Pharmacology & Therapeutics. 2008;84(3):347-361.
[22] Johnson J, Boerwinkle E, Zineh I, Chapman A, Bailey K,
Cooper-DeHoff R et al. Pharmacogenomics of antihypertensive drugs:
Rationale and design of the Pharmacogenomic Evaluation of
Antihypertensive Responses (PEAR) study. American Heart Journal.
2009;157(3):442-449.
[23] Brewster L, van Montfrans G, Oehlers G, Seedat Y. Systematic
review: antihypertensive drug therapy in patients of African and South
Asian ethnicity. Internal and Emergency Medicine. 2016;11(3):355-374.
[24] Ritchey M, Chang A, Powers C, Loustalot F, Schieb L, Ketcham M
et al. Vital Signs: Disparities in Antihypertensive Medication
Nonadherence Among Medicare Part D Beneficiaries — United States,
2014. MMWR Morbidity and Mortality Weekly Report. 2016;65(36):967-976.
[25] Lauffenburger J, Robinson J, Oramasionwu C, Fang G.
Racial/Ethnic and Gender Gaps in the Use of and Adherence to
Evidence-Based Preventive Therapies Among Elderly Medicare Part D
Beneficiaries After Acute Myocardial Infarction. Circulation.
2014;129(7):754-763.
[26] Zhang Y, Baik S. Race/Ethnicity, Disability, and Medication
Adherence Among Medicare Beneficiaries with Heart Failure. Journal of
General Internal Medicine. 2013;29(4):602-607.
[27] Liu Q, Quan H, Chen G, Qian H, Khan N. Antihypertensive
Medication Adherence and Mortality According to Ethnicity: A Cohort
Study. Canadian Journal of Cardiology. 2014;30(8):925-931.
[28] Kandaswamy E, Zuo L. Recent Advances in Treatment of Coronary
Artery Disease: Role of Science and Technology. International Journal of
Molecular Sciences. 2018;19(2):424.
[29] Zaman M, Philipson P, Chen R, Farag A, Shipley M, Marmot M et
al. South Asians and coronary disease: is there discordance between
effects on incidence and prognosis?. Heart. 2013;99(10):729-736.
[30] Tillin T, Hughes A, Mayet J, Whincup P, Sattar N, Forouhi N et
al. The Relationship Between Metabolic Risk Factors and Incident
Cardiovascular Disease in Europeans, South Asians, and African
Caribbeans. Journal of the American College of Cardiology.
2013;61(17):1777-1786.
[31] Jose P, Frank A, Kapphahn K, Goldstein B, Eggleston K, Hastings
K et al. Cardiovascular Disease Mortality in Asian Americans. Journal of
the American College of Cardiology. 2014;64(23):2486-2494.
[32] King K, Khan N, Quan H. Ethnic Variation in Acute Myocardial
Infarction Presentation and Access to Care. The American Journal of
Cardiology. 2009;103(10):1368-1373.
[33] Zaman M, Crook A, Junghans C, Fitzpatrick N, Feder G, Timmis A
et al. Ethnic differences in long-term improvement of angina following
revascularization or medical management: a comparison between south
Asians and white Europeans. Journal of Public Health.
2008;31(1):168-174.
[34] Iantorno M, Rogers T, Torguson R, Kolm P, Gajanana D, Khalid N
et al. Racial Disparities in Clinical Characteristics and Outcomes of
Women Undergoing Percutaneous Coronary Intervention. Cardiovascular
Revascularization Medicine. 2019;20(12):1039-1042.
[35] Mehta R, Shahian D, Sheng S, O’Brien S, Edwards F, Jacobs J et
al. Association of Hospital and Physician Characteristics and Care
Processes With Racial Disparities in Procedural Outcomes Among
Contemporary Patients Undergoing Coronary Artery Bypass Grafting
Surgery. Circulation. 2016;133(2):124-130.
[36] van Ryn M, Burgess D, Malat J, Griffin J. Physicians’
perceptions of patients’ social and behavioural characteristics and race
disparities in treatment recommendations for men with coronary artery
disease. Am J Public Health . 2006;96(2):351-357.
[37] Mody P, Gupta A, Bikdeli B, Lampropulos J, Dharmarajan K. Most
Important Articles on Cardiovascular Disease Among Racial and Ethnic
Minorities. Circulation: Cardiovascular Quality and Outcomes. 2012;5(4).
[38] Cavender M, Rassi A, Fonarow G, Cannon C, Peacock W, Laskey W
et al. Relationship of Race/Ethnicity With Door-to-Balloon Time and
Mortality in Patients Undergoing Primary Percutaneous Coronary
Intervention for ST-Elevation Myocardial Infarction: Findings From Get
With the Guidelines-Coronary Artery Disease. Clinical Cardiology.
2013;36(12):749-756.
[39] Albert MA, Ayanian JZ, Silbaugh TS, et al. Early results of
Massachusetts healthcare reform on racial, ethnic, and socioeconomic
disparities in cardiovascular care. Circulation 2014;
129(24):2528–2538.
[40] Burton B, Munir N, Labastide A, Sanchez R, Gabriel R. An Update
on Racial Disparities With 30-Day Outcomes After Coronary Artery Bypass
Graft Under the Affordable Care Act. Journal of Cardiothoracic and
Vascular Anesthesia. 2019;33(7):1890-1898.
[41] Leigh J, Alvarez M, Rodriguez C. Ethnic Minorities and Coronary
Heart Disease: an Update and Future Directions. Current Atherosclerosis
Reports. 2016;18(2).
[42] Leigh J, Alvarez M, Rodriguez C. Ethnic Minorities and Coronary
Heart Disease: an Update and Future Directions. Current Atherosclerosis
Reports. 2016;18(2).
[43] Gijsberts C, Seneviratna A, de Carvalho L, den Ruijter H,
Vidanapthirana P, Sorokin V et al. Ethnicity Modifies Associations
between Cardiovascular Risk Factors and Disease Severity in Parallel
Dutch and Singapore Coronary Cohorts. PLOS ONE. 2015;10(7):e0132278.
[44] Colilla S, Crow A, Petkun W, Singer D, Simon T, Liu X.
Estimates of Current and Future Incidence and Prevalence of Atrial
Fibrillation in the U.S. Adult Population. The American Journal of
Cardiology. 2013;112(8):1142-1147.
[45] Shih T, Ledezma K, McCauley M, Rehman J, Galanter W, Darbar D.
Impact of traditional risk factors for the outcomes of atrial
fibrillation across race and ethnicity and sex groups. IJC Heart &
Vasculature. 2020;28:100538.
[46] Meschia J, Merrill P, Soliman E, Howard V, Barrett K, Zakai N
et al. Racial Disparities in Awareness and Treatment of Atrial
Fibrillation. Stroke. 2010;41(4):581-587.
[47] Golwala H, Jackson L, Simon D, Fonarow G, Chang P, Gersh B et
al. Racial/Ethnic Differences in Atrial Fibrillation Symptoms, Treatment
Patterns and Outcomes: Insights from Outcomes Registry for Better
Informed Treatment for Atrial Fibrillation (ORBIT-AF) Registry. Journal
of the American College of Cardiology. 2015;65(10):A462.
[48] Mistry A, Vali Z, Sidhu B, Budgeon C, Yuyun M, Pooranachandran
V et al. Disparity in implantable cardioverter defibrillator therapy
among minority South Asians in the United Kingdom. Heart.
2020;106(9):671-676.
[49] Yuyun M, Squire I, Ng G, Samani N. Evidence for reduced
susceptibility to cardiac bradycardias in South Asians compared with
Caucasians. Heart. 2018;104(16):1350-1355.
[50] Ugowe F, Jackson L, Thomas K. Racial and ethnic differences in
the prevalence, management, and outcomes in patients with atrial
fibrillation: A systematic review. Heart Rhythm. 2018;15(9):1337-1345.
[51] Khurshid S, Choi S, Weng L, Wang E, Trinquart L, Benjamin E et
al. Frequency of Cardiac Rhythm Abnormalities in a Half Million Adults.
Circulation: Arrhythmia and Electrophysiology. 2018;11(7)
[52] Stamos T, Darbar D. The “Double” Paradox of Atrial
Fibrillation in Black Individuals. JAMA Cardiology. 2016;1(4):377.
[53] Amponsah M, Benjamin E, Magnani J. Atrial Fibrillation and Race
– A Contemporary Review. Current Cardiovascular Risk Reports.
2013;7(5):336-345.
[54] Shen A, Chen W, Yao J, Brar S, Wang X, Go A. Effect of
Race/Ethnicity on the Efficacy of Warfarin. CNS Drugs.
2008;22(10):815-825.
[55] Essien U, Holmes D, Jackson L, Fonarow G, Mahaffey K, Reiffel J
et al. Association of Race/Ethnicity With Oral Anticoagulant Use in
Patients With Atrial Fibrillation. JAMA Cardiology. 2018;3(12):1174.
[56] Tedla Y, Schwartz S, Silberman P, Greenland P, Passman R.
Racial Disparity in the Prescription of Anticoagulants and Risk of
Stroke and Bleeding in Atrial Fibrillation Patients. Journal of Stroke
and Cerebrovascular Diseases. 2020;29(5):104718.
[57] Zhang T, Tsang W, Wijeysundera H, Ko D. Reporting and
representation of ethnic minorities in cardiovascular trials: A
systematic review. American Heart Journal. 2013;166(1):52-57.
[58] Felker G, Mann D. Heart Failure E-Book : A Companion to
Braunwald’s Heart Disease. 3rd ed. Philadelphia PA: Elsevier; 2016.
[59] Blackledge H, Newton J, Squire I. Prognosis for South Asian and
white patients newly admitted to hospital with heart failure in the
United Kingdom: historical cohort study. BMJ. 2003;327(7414):526-531.
[60] Chaturvedi N. Ethnic Differences in Cardiovascular Disease.
Heart. 2003;89(6):681-686.[61] Sun L, Kimmoun A, Takagi K, Liu P,
Bader Eddeen A, Mebazaa A. Ethnic differences in acute heart failure
outcomes in Ontario. International Journal of Cardiology.
2019;291:177-182.
[62] Choi D, Nemi E, Fernando C, Gupta M, Moe G. Differences in the
Clinical Characteristics of Ethnic Minority Groups With Heart Failure
Managed in Specialized Heart Failure Clinics. JACC: Heart Failure.
2014;2(4):392-399.
[63] Ziaeian B, Heidenreich P, Xu H, DeVore A, Matsouaka R,
Hernandez A et al. Race/Ethnic Differences in Outcomes Among
Hospitalized Medicare Patients With Heart Failure and Preserved Ejection
Fraction. JACC: Heart Failure. 2017;5(7):483-493.
[64] Kamath S, Drazner M, Wynne J. Characteristics and Outcomes in
African American Patients With Decompensated Heart Failure. Archives of
Internal Medicine. 2008;168(11):1152.
[65] Lai E, Grubisic M, Palepu A, Quan H, King K, Khan N. Cardiac
medication prescribing and adherence after acute myocardial infarction
in Chinese and South Asian Canadian patients. BMC Cardiovascular
Disorders. 2011;11(1).
[66] Chong E, Wang H, King-Shier K, Quan H, Rabi D, Khan N.
Prescribing patterns and adherence to medication among South-Asian,
Chinese and white people with Type 2 diabetes mellitus: a
population-based cohort study. Diabetic Medicine. 2014;31(12):1586-1593.
[67] Franciosa J, Ferdinand K, Yancy C. Treatment of Heart Failure
in African Americans: A Consensus Statement. Congestive Heart Failure.
2010;16(1):27-38.
[68] Vardeny O, Cavallari L, Claggett B, Desai A, Anand I, Rossignol
P et al. Race Influences the Safety and Efficacy of Spironolactone in
Severe Heart Failure. Circulation: Heart Failure. 2013;6(5):970-976.
[69] Shekelle PG, Rich MW, Morton SC, Atkinson CS, Tu W, Maglione M,
et al. Efficacy of angiotensin-converting enzyme inhibitors and
beta-blockers in the management of left ventricular systolic dysfunction
according to race, gender, and diabetic status: a meta-analysis of major
clinical trials. J Am Coll Cardiol. 2003;41(9):1529–38.
[70] Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A et
al. 2016 ESC Guidelines for the diagnosis and treatment of acute and
chronic heart failure. European Heart Journal. 2016;37(27):2129-2200.
[71] Sahni S, Horwich T, Fonarow G. Racial and Ethnic Differences in
Heart Failure Etiology, Prognosis, and Management. Current
Cardiovascular Risk Reports. 2014;9(1).
[72] Horne R, Weinman J. Patients’ beliefs about prescribed
medicines and their role in adherence to treatment in chronic physical
illness. J Psychosom Res. 1999;47(6):555–67. doi:
10.1016/S0022-3999(99)00057-4.
[73] Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary
prevention of coronary heart disease in women through diet and
lifestyle. N Engl J Med. 2000;343(1):16–22.
[74] Bhatnagar A. Environmental determinants of cardiovascular
disease. Circ Res. 2017;121(2):162–80.
[75] Egede LE. Race, ethnicity, culture, and disparities in health
care. J Gen Intern Med. 2006;21(6):667–9.
[76] Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C,
Bangdiwala SI, AlHabib KF, et
al. Socioeconomic status and risk of cardiovascular disease in 20
low-income, middle-income, and
high-income countries: the Prospective Urban Rural Epidemiologic (PURE)
study. Lancet Glob
Health. 2019;7(6):e748–60.
[77] Dhungana RR, Thapa P, Devkota S, Banik PC, Gurung Y, Mumu SJ,
et al. Prevalence of cardiovascular disease risk factors: A
community-based cross-sectional study in a peri-urban community of
Kathmandu, Nepal. Indian Heart J. 2018;70:S20–7.
[78] Eriksen A, Tillin T, O’Connor L, Brage S, Hughes A, Mayet J, et
al. The impact of health behaviours on incident cardiovascular disease
in Europeans and south Asians – A prospective analysis in the UK SABRE
study. PLoS One. 2015;10(3):e0117364.
[79] Brewer LC, Cooper LA. Race, Discrimination, and Cardiovascular
Disease. AMA J Ethics. 2014;16(6):455–60.
[80] Hill A, Jones D, Woodworth L. Physician-patient race-match
reduces patient mortality [Internet]. 2020 [cited 2020 Aug 23].
Available from: https://papers.ssrn.com/abstract=3211276